The Clinical and Economic Benefits of GnRH Agonist in Treating Endometriosis

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Stakeholders

Academia
Employers
Health System
Payers
Providers

Topics

Clinical
Health Care Cost
Health Care Delivery
Insurance
Policy
Technology
Value-Based Care

Institute for Value-Based Medicine

All Coverage
Event Coverage
Interviews
News

About AJMC

AJMC Journals
Anniversary
Author Forms
Authors
Nominate a Rising Leader

About Us
Contact
Editorial Staff
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy

The Clinical and Economic Benefits of GnRH Agonist in Treating Endometriosis

May 1, 1999

An Interview with Mark Glasser, MD

Supplements and Featured Publications, Creating an Optimal Strategy for Treating Endometriosis and Chronic Pelvic Pain, Volume 5, Issue 5 Suppl